Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment

被引:4
作者
Jehn, Christian F. [1 ]
Diel, Ingo J.
Overkamp, Friedrich
Kurth, Andreas [2 ]
Schaefer, Reinhold
Miller, Kurt [3 ]
Lueftner, Diana [1 ]
机构
[1] Univ Hosp Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[2] THEMISTOCLES GLUCK Hosp Ratingen, Ratingen, Germany
[3] Univ Hosp Charite, Dept Urol, Berlin, Germany
关键词
Metastatic bone disease; algorithm for diagnostic and treatment; bone-targeted agents; skeletal morbidity; multidisciplinary management; vertebral bone metastasis; non-vertebral bone metastasis; review; SKELETAL-RELATED EVENTS; PROSTATE-CANCER; BREAST-CANCER; ZOLEDRONIC ACID; SOLID TUMORS; DOUBLE-BLIND; ANDROGEN-DEPRIVATION; DENOSUMAB; BISPHOSPHONATES; COMPLICATIONS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Bone is a frequent site of metastases in advanced cancer and is associated with significant skeletal morbidity. Current treatment options are aimed at preserving and improving functional independence and quality of life. Materials and Methods: A review of current literature focusing on diagnostic tools and treatment approaches of bone metastasis in advanced cancer was performed and conclusions were incorporated into diagnostic and treatment algorithms. Results: Radiologic imaging has added valuable tools for screening and diagnostics of bone metastasis. Clinical management of skeletal metastasis includes improved pain management, introduction of bone modifying agents and advancements in surgical and radiation therapy. We propose three algorithms enhancing the sensitivity of diagnostics and improving multidisciplinary management of vertebral and non-vertebral bone metastasis. Conclusion: Bone metastases are an expression of a systemic disease. Treatment options include highly specialized modalities yet need to be tailored to individual needs. Algorithms help standardize treatment procedures and can improve treatment outcome in a multidisciplinary setting.
引用
收藏
页码:2631 / 2637
页数:7
相关论文
共 56 条
[11]   Effects of Bone-Targeted Agents on Cancer Progression and Mortality [J].
Coleman, Robert ;
Gnant, Michael ;
Morgan, Gareth ;
Clezardin, Philippe .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (14) :1059-1067
[12]   Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study [J].
Coleman, Robert E. ;
Banks, Linda M. ;
Girgis, Samia I. ;
Kilburn, Lucy S. ;
Vrdoljak, Eduard ;
Fox, John ;
Cawthorn, Simon J. ;
Patel, Ashraf ;
Snowdon, Claire F. ;
Hall, Emma ;
Bliss, Judith M. ;
Coombes, R. Charles .
LANCET ONCOLOGY, 2007, 8 (02) :119-127
[13]   Bisphosphonates in oncology [J].
Coleman, Robert E. ;
McCloskey, Eugene V. .
BONE, 2011, 49 (01) :71-76
[14]   Endogenous hormones and the risk of hip and vertebral fractures among older women [J].
Cummings, SR ;
Browner, WS ;
Bauer, D ;
Stone, K ;
Ensrud, K ;
Jamal, S ;
Ettinger, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :733-738
[15]  
Domchek SM, 2000, CANCER, V89, P363, DOI 10.1002/1097-0142(20000715)89:2<363::AID-CNCR22>3.0.CO
[16]  
2-3
[17]   Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer [J].
Fisch, Michael J. ;
Lee, Ju-Whei ;
Weiss, Matthias ;
Wagner, Lynne I. ;
Chang, Victor T. ;
Cella, David ;
Manola, Judith B. ;
Minasian, Lori M. ;
McCaskill-Stevens, Worta ;
Mendoza, Tito R. ;
Cleeland, Charles S. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) :1980-1988
[18]   Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study [J].
Fizazi, Karim ;
Carducci, Michael ;
Smith, Matthew ;
Damiao, Ronaldo ;
Brown, Janet ;
Karsh, Lawrence ;
Milecki, Piotr ;
Shore, Neal ;
Rader, Michael ;
Wang, Huei ;
Jiang, Qi ;
Tadros, Sylvia ;
Dansey, Roger ;
Goessl, Carsten .
LANCET, 2011, 377 (9768) :813-822
[19]   Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates [J].
Fizazi, Karim ;
Lipton, Allan ;
Mariette, Xavier ;
Body, Jean-Jacques ;
Rahim, Yasmin ;
Gralow, Julie R. ;
Gao, Guozhi ;
Wu, Ling ;
Sohn, Winnie ;
Jun, Susie .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) :1564-1571
[20]   Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours [J].
Ford, J. ;
Cummins, E. ;
Sharma, P. ;
Elders, A. ;
Stewart, F. ;
Johnston, R. ;
Royle, P. ;
Jones, R. ;
Mulatero, C. ;
Todd, R. ;
Mowatt, G. .
HEALTH TECHNOLOGY ASSESSMENT, 2013, 17 (29) :1-+